US Patent Issued to AstraZeneca on June 16 for "POLQ inhibitors" (British, American Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,828, issued on June 16, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"POLQ inhibitors" was invented by Bernard Barlaam (Cambridge, Great Britain), Michael Bodnarchuk (Cambridge, Great Britain), Gail Wrigley (Cambridge, Great Britain), Jon Winter-Holt (Cambridge, Great Britain), Oliver Turner (Cambridge, Great Britain), Ariamala Gopalsamy (Wilmington, Del.), Jason Shields (Wilmington, Del.), Sofia Ferrer Cabrera (Cambridge, Great Britain) and Helen Elizabeth Jones (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The specification generally relates to compounds of Formula (I):or a stereoisomer or pharmaceutically salt t...